0.9472

13.89% -0.1528

Pre-market: .79 -0.1572 -16.60%

Hcw Biologics Inc (HCWB)

Overview News Price History Financials Discussions Forecast

Hcw Biologics Inc stock is traded at $0.9472, with a volume of 7.28M. It is down -13.89% in the last 24 hours and up +82.12% over the past month. HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Previous Close:

$1.10

Open:

$0.93

24h Volume:

7.28M

Relative Volume:

0.84

Market Cap:

$38.20M

Revenue:

$3.50M

Net Income/Loss:

$-37.33M

P/E Ratio:

-1.8215

EPS:

-0.52

Net Cash Flow:

$-19.15M

1W Performance:

+205.55%

1M Performance:

+82.12%

6M Performance:

-14.67%

1Y Performance:

-12.30%

1-Day Range:

$0.81

$1.11

1-Week Range:

$0.2761

$2.52

52-Week Range:

$0.2761

$2.52

Hcw Biologics Inc Stock (HCWB) Company Profile

Name

Hcw Biologics Inc

Sector

Healthcare (1193)

Industry

Biotechnology (683)

Phone

954-842-2024

Address

2929 N COMMERCE PKWY, MIRAMAR

Employee

Twitter

Next Earnings Date

Latest SEC Filings

HCWB's Discussions on Twitter

Compare HCWB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCWB	0.9472	38.20M	3.50M	-37.33M	-19.15M	-0.52
VRTX	451.23	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	743.35	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.82	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.79	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.14	24.49B	3.30B	-501.07M	1.03B	11.54

Hcw Biologics Inc Stock (HCWB) Latest News

Nov 20, 2024

HCW Biologics Expands with New Financial Agreements - TipRanks

Nov 20, 2024

HCW Biologics prices $6.9M registered direct offering at $1.03 per share - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga

Nov 19, 2024

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com

Nov 19, 2024

Hcw Biologics Inc (HCWB)

Hcw Biologics Inc Stock (HCWB) Company Profile

Compare HCWB with other stocks

Hcw Biologics Inc Stock (HCWB) Latest News

HCW Biologics Expands with New Financial Agreements - TipRanks

HCW Biologics prices $6.9M registered direct offering at $1.03 per share - Yahoo Finance

Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com

HCW Biologics announces pricing of $6.9M registered direct offering, concurrent private placement - MSN

HCW Biologics Secures $6.9M Above-Market Offering with Warrant Coverage | HCWB Stock News - StockTitan

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules - Benzinga

HCW Biologics Announces Pricing of $6.9 Million Registered - GlobeNewswire

Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge - BP Journal

Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase Program Boosts Investor Confidence - BP Journal

HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement Sends Stock Up Over 310% - BP Journal

U.S. STOCKS Henry Schein Inc, Palantir Technologies, Uber Technologies - XM

Owning 44% shares,institutional owners seem interested in Jamieson Wellness Inc. (TSE:JWEL), - Yahoo Finance

Trinity Investors Managing Partner Sanjay Chandra Named One of Dallas Most Influential Leaders on DCEO’s Dallas 500 List - Yahoo Finance

HCW Biologics Shares Surge on License Agreement - MarketWatch

Broward pharma developer inks $7 million deal with Chinese firm - The Business Journals

Enphase Energy Powers Up with US-Made IQ Batteries: Unlocking Bonus Tax Credits - AOL

California logistics company files for Chapter 11 - Yahoo Finance

Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November - Benzinga

Spirit Airlines Declares Bankruptcy After Failed Merger and Rising Costs - Yahoo Finance

Stock Market News: HCW Biologics increase by 521.18% while CareMax drops by 49.20% during mid day trading - Business Upturn

Ultra low-cost carrier Spirit Airlines files for bankruptcy - Yahoo Finance

U.S. STOCKS Tesla Inc, Palantir Technologies and Super Micro Computer Inc - XM

Nvidia Stock Drops on Report of Snag With Blackwell Chip Servers - Yahoo Finance

Why Is Penny Stock HCW Biologics Surging On Monday? - Yahoo Finance

Dow Falls 100 Points; Brady Posts Upbeat Results - Benzinga

Stock market today: CareMax(−41.19%), HCW Biologics(+209.06%) among the most volatile stocks in early trading - Business Upturn

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate - GlobeNewswire

This tiny U.S biotech has made a big deal in China - RagingBull

HCW Biologics signs licensing deal with WY Biotech - Investing.com

Kandi Technologies Reports Third Quarter 2024 Financial Results - The Manila Times

HCW Biologics jumps on license agreement for immunotherapeutic product candidate - Seeking Alpha

MedinCell And 2 Other Top Growth Stocks With Strong Insider Ownership - Yahoo Finance

HCW Biologics Inc. and Wy Biotech Announce License Agreement for Immunotherapeutic Product Candidate - Marketscreener.com

Here's What Analysts Are Forecasting For ESCO Technologies Inc. (NYSE:ESE) After Its Yearly Results - Yahoo Finance

dynaCERT Third Quarter 2024 Earnings: CA$0.008 loss per share (vs CA$0.004 loss in 3Q 2023) - Yahoo Finance

Armlogi Holding First Quarter 2025 Earnings: US$0.11 loss per share (vs US$0.069 profit in 1Q 2024) - Yahoo Finance

HCW Biologics Third Quarter 2024 Earnings: US$0.10 loss per share (vs US$0.14 loss in 3Q 2023) - Simply Wall St

There's Been No Shortage Of Growth Recently For Royal Caribbean Cruises' (NYSE:RCL) Returns On Capital - Yahoo Finance

Samko Timber Third Quarter 2024 Earnings: Rp16.00 loss per share (vs Rp105 loss in 3Q 2023) - Yahoo Finance

Applied Materials Shares Slide on Disappointing Sales Forecast - Yahoo Finance

Analysts Have Made A Financial Statement On FiscalNote Holdings, Inc.'s (NYSE:NOTE) Third-Quarter Report - Yahoo Finance

OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target - Yahoo Finance

GCM Grosvenor (NASDAQ:GCMG) Is Paying Out A Dividend Of $0.11 - Yahoo Finance

November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance

HCW Biologics Inc. (HCWB) Quarterly 10-Q Report - Quartz

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights - The Manila Times

HCW Biologics Q3 Revenue Falls 50%, Faces $14.4M Legal Obligations Amid Going Concern | HCWB Stock News - StockTitan

Bank of America CEO Brian Moynihan on Trump, the Fed, & regulation - Yahoo Finance

Should Value Investors Buy Pfizer (PFE) Stock? - Yahoo Finance

HCWB stock touches 52-week low at $0.4 amid market challenges - Investing.com Australia

Hcw Biologics Inc Stock (HCWB) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to HCWB